Medical Device Company
Appears in 1 story
Competitor with FDA-approved PearlMatrix P-15 bone graft
Medtronic's INFUSE bone graft has spent 24 years navigating FDA approval, off-label controversy, and lawsuits. The FDA just approved INFUSE for transforaminal lumbar interbody fusion (TLIF) procedures—the only growth factor bone graft approved for two-level spinal constructs and the only one cleared for anterior, oblique, and transforaminal approaches.
Updated May 29
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
